RxDoctor Payments Data

Victor Micolucci, MD

Family Medicine · Jacksonville, FLNPI 1568487478

Payments from drug & device makers

$29,180in general payments, 2019–2025

Across 1,259 payments — averaging $23.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • Novo Nordisk$3K
  • Amgen$2K
  • AbbVie$2K
  • Abbott$2K
  • GSK$2K
  • plus $15K from 54 others

What the payments were for

  • Food & beverage$28,96899%
  • Education$940%
  • Gifts$1190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca114$3,441
Novo Nordisk124$2,758
Amgen(2 entities)73$2,407
AbbVie(2 entities)136$1,845
Abbott77$1,824
GSK57$1,743
Lilly USA, LLC51$956
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC49$914
Johnson & Johnson30$898
Boehringer Ingelheim39$792
Pfizer40$631
Bayer33$630
Otsuka America Pharmaceutical, Inc.26$598
Mylan Specialty L.p.20$565
Astellas Pharma US Inc27$560
Takeda Pharmaceuticals U.S.A., Inc.24$556
Corcept Therapeutics27$544
Merck23$528
Avanir Pharmaceuticals, Inc.27$447
Sunovion Pharmaceuticals Inc.26$411
Sanofi-aventis U.S. LLC25$401
Stryker3$392
Biohaven Pharmaceuticals, Inc.10$385
Amarin Pharma, Inc.16$347
Evoke Pharma, Inc.6$336
Boston Scientific4$286
SK Life Science, Inc.5$269
Medtronic4$252
Novartis14$235
Eisai Inc.16$234
Recor Medical Inc1$166
Xeris Pharmaceuticals, Inc.8$162
Abiomed1$129
E.r. Squibb & Sons, L.L.C.8$128
Indivior Inc.2$120
Mannkind Corporation2$119
Dexcom, Inc.2$117
Scilex Pharmaceuticals Inc.7$115
Endo Pharmaceuticals Inc.9$114
Exactech, Inc.1$109
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)6$100
Sumitomo Pharma America, Inc.5$98
Team 1, LLC1$97
Daiichi Sankyo Inc.6$96
Protega Pharmaceutials Inc2$94
Insulet Corporation5$80
OPKO Pharmaceuticals, LLC4$77
Teva Pharmaceuticals USA, Inc.6$77
Exact Sciences5$77
Biohaven Pharmaceutical Holding Company Ltd.4$68
Idorsia Pharmaceuticals US Inc4$64
Grifols USA, LLC3$60
Esperion Therapeutics, Inc.3$57
Phathom Pharmaceuticals, Inc.2$52
Globus Medical2$51
Impulse Dynamics (USA) Inc.3$50
Sanofi Pasteur Inc.3$45
Currax Pharmaceuticals LLC3$42
Arbor Pharmaceuticals, Inc.3$38
Adlon Therapeutics L.p.2$35

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,180 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$146,099
Medicare patients
215
Services billed
3,449

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban94$94,902
OzempicSemaglutide59$67,104
Trelegy ElliptaFluticasone/Umeclidin/Vilanter75$53,214
MounjaroTirzepatide40$49,657
JardianceEmpagliflozin44$48,715
RybelsusSemaglutide28$46,122
LinzessLinaclotide46$41,571
NuedextaDextromethorphan Hbr/Quinidine23$38,467
XareltoRivaroxaban43$34,388
FarxigaDapagliflozin Propanediol37$32,582
MyrbetriqMirabegron33$28,537
JanuviaSitagliptin Phosphate22$27,554
ProliaDenosumab14$24,881
Repatha SureclickEvolocumab32$21,486
Soliqua 100-33Insulin Glargine/Lixisenatide28$21,399

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$2,758$113,22687 claims
PfizerEliquis$631$94,90294 claims
Lilly USA, LLCMounjaro, Trulicity$956$66,96756 claims
Boehringer IngelheimJardiance, Trijardy Xr$792$64,93758 claims
GSKTrelegy Ellipta, Anoro Ellipta$1,743$63,42486 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$3,441$53,97290 claims
Johnson & JohnsonXarelto, Invokamet$898$42,21654 claims
MerckJanuvia, Belsomra$528$41,86754 claims
AbbVieLinzess$1,845$41,57146 claims
Avanir Pharmaceuticals, Inc.Nuedexta$447$38,46723 claims
Astellas Pharma US IncMyrbetriq$560$28,53733 claims
AmgenProlia$2,407$24,88114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →